Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Small Molecule
      Early Development
    • Small Molecule
      Late Development
    • Route Scouting and Selection
    • High Potency APIs
    • Solid State & Preformulation
    • Analytical Science
    • Separation Science
    • Oligonucleotides
    • Peptides
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
News
CatSci Ltd Wins SMART Capital Equipment Grant to Open Second Oligonucleotides Lab to Drive Innovation in RNA Therapeutics
News

CatSci Ltd Wins SMART Capital Equipment Grant to Open Second Oligonucleo...

Oct 8th 2024
CatSci and Reach Industries Win Innovate UK Grant to Accelerate Development of Oligonucleotides
News

CatSci and Reach Industries Win Innovate UK Grant to Accelerate Developm...

Aug 5th 2024
CatSci Achieves 2024 Bronze EcoVadis Sustainability Rating
News

CatSci Achieves 2024 Bronze EcoVadis Sustainability Rating

Jul 17th 2024
CatSci Announces Strategic Acquisition of Reach Separations to Offer End-To-End Separation Science Support from Discovery to Manufacture
News

CatSci Announces Strategic Acquisition of Reach Separations to Offer End...

Jun 25th 2024
CatSci Wins ESG Excellence Award for Commitment to Environmental, Social, and Governance (ESG) Principles
News

CatSci Wins ESG Excellence Award for Commitment to Environmental, Social...

May 23rd 2024
CatSci Ltd Achieve Cyber Essentials Certified Plus Accreditation
News

CatSci Ltd Achieve Cyber Essentials Certified Plus Accreditation

Mar 5th 2024
CatSci Win Welsh Government Grant for Innovative Oligonucleotides Development
News

CatSci Win Welsh Government Grant for Innovative Oligonucleotides Develo...

Mar 4th 2024
CatSci Ltd Strengthens Team with New Senior Business Development Manager in North America, Carlos R. Côté
News

CatSci Ltd Strengthens Team with New Senior Business Development Manager...

Feb 12th 2024
CatSci Ltd Announce Strategic Partnership with Reach Separations to Offer End-to-End Analytical Support from Discovery to Manufacture
News

CatSci Ltd Announce Strategic Partnership with Reach Separations to Offe...

Nov 28th 2023
CatSci Ltd Expand Capabilities to Offer Expert cGMP Analytical Development Services
News

CatSci Ltd Expand Capabilities to Offer Expert cGMP Analytical Developme...

Nov 21st 2023

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • CatSci Corporate and Social Responsibility (CSR) Policy
  • Sustainability Report 2024

What we do

  • Small Molecule Late Development
  • Small Molecule Early Development
  • Route Scouting and Selection
  • Analytical Science
  • High Potency APIs
  • Solid State and Preformulation
  • Oligonucleotides

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients in need. 

© 2025 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.